T2D

15 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(3)

Phase 2(4)

Drug	Company
ALN-4324	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
asc30	CHINA PHARMA HOLDINGS, INC. (CPHI)
GSBR-1290	Structure Therapeutics Inc. (GPCR)
vanoglipel	MetaVia Inc. (MTVA)

Phase 1(1)

Drug	Company
AGTX-2004 (DBPR211)	Agentix Corp. (AGTX)

Preclinical(1)

Drug	Company
rjva-001	Fractyl Health Inc. (GUTS)

Phase 1/Phase 2(1)

Drug	Company
ALN-KHK	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 4(5)

Drug	Company
gla-100	Sanofi (SNYNF)
gla-100	Sanofi (SNY)
iglarlixi	Sanofi (SNY)
iglarlixi	Sanofi (SNY)
Semaglutide	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 15 drugs in development for T2D across 11 companies.

There are 1 clinical trial targeting T2D tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.